Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Drug Resistant Suppliers In Europe
25 companies found
based inRotkreuz, SWITZERLAND
Roche Diagnostics is a division of Roche. We develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, we offer the industry’s most comprehensive in vitro ...
GenMark’s ePlex® Blood-Culture Identification (BCID) Panels provide broad coverage of organisms that can lead to sepsis along with their resistance genes. This broad coverage means that about 95% of currently identified bloodstream ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
based inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
based inParis, FRANCE
CHROMagar™ was incorporated in 1993 by the inventor, and pioneer in chromogenic culture media technology, Dr Alain Rambach. Established in the heart of Paris (France) close to the famous Pasteur Institute where Dr Rambach began his research career, ...
Performance: β-Lactamase production (ESBL, AmpC, carbapenemase) is the most common mechanism of β-lactam drug resistance in Gram negative bacteria. Each of the involved mechanisms can be plasmid-encoded ...
based inSydney, AUSTRALIA
Nanosonics is an Australian infection prevention company that has successfully developed and commercialised a unique automated disinfection technology, trophon, representing the first major innovation in high level disinfection for ultrasound probes ...
Every day, 82,000 patients are protected from the risk of cross contamination because the ultrasound probe has been high-level disinfected with the trophon ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
CancertrackTM is a non-invasive blood based investigation that detects cancer derived biomarkers with ultra-high precision, specificity and reliability. CancertrackTM can be used to monitor the disease /recurrence or changes in the tumor ...
based inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
based inTralee, IRELAND
BioAtlantis was established in 2004 and entered the crop biostimulant market in 2007 with stress mitigation as a central strategy. Stress is now recognised worldwide as affecting most life forms. It can be split into two main categories, abiotic and ...
based inCantanhede, PORTUGAL
For a safer tomorrow developing immunotherapies to address life threatening bacterial infections. Immunethep is a biotech startup company (spin-off from the University of Porto) that is developing anti-bacterial immunotherapies based on the ...
Immunethep has developed an anti-bacterial immunotherapy based on the discovery of a virulence mechanism shared by a set of different pathogenic ...
based inMarchaux - Chaudefontaine, FRANCE
DIXI medical, Manufacturer of intracerebral electrodes for the localization of epileptic foci for over 40 years. For more than 40 years, DIXI medical never ceased to innovate and improve its intracerebral electrodes and implantation accessories, ...
based inHilden, GERMANY
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins ...
based inHouston, TEXAS (USA)
LivaNova is a global medical technology company built on decades of experience and a relentless commitment to patients. Our focus is transforming lives with products and therapies for the head and heart. It’s health innovation that truly matters. ...
based inBristol, UNITED KINGDOM
A-Gas, founded in 1993, is a market leader in the supply of refrigerants within its core territories in the UK, Australia and South Africa, with modern state-of-the-art recovery and reclamation, storage, blending and packaging facilities for ...
based inBerlin, GERMANY
MerLion Pharmaceuticals is a biopharma company focusing on the research and development of drugs for the treatment of serious bacterial infections. MerLion - located in Berlin-Buch, Germany - manages the non-clinical and clinical development as well ...
Finafloxacin is a novel candidate for the treatment of multiple, life-threatening infection indications, like complicated urinary tract infections (cUTIs). Coming from a well-known and well understood “workhorse” class of antibiotic, its ...
based inEmmendingen, GERMANY
Biomedical technology – developed and manufactured in Germany: inomed is the first choice for medical specialists worldwide. Cost-effective clinical outcomes and patient safety are the highest priorities in today's healthcare environment. Biomedical ...
In combination with the sEEG-Box, it is possible to perform RF treatments via sEEG electrodes. sEEG (stereoelectroencephalography) is an invasive, diagnostic procedure for patients with drug-resistant ...
based inSnailwell, UNITED KINGDOM
Tristel is a manufacturer of infection control, contamination control and hygiene products. It has four principal activities: Medical Instrument Disinfection under the Tristel brand. Hospital Surface Disinfection under the Cache brand. Cleanroom, ...
based inMont-Saint-Guibert, BELGIUM
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, ...
Genio is the disruptive sleep apnea solution for patients who suffer from moderate to severe Obstructive Sleep Apnea or OSA. Genio is the world’s first and unique battery-free, leadless, full body MR conditional and minimally invasive ...
based inLeverkusen, GERMANY
Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to help people and planet thrive by supporting efforts to address the unprecedented global challenges ...
Traditionally, many small molecule drugs follow the same basic mechanism of action to treat diseases: They inhibit the function of a target protein that has an active role in a disease. To do so, they require a tractable active binding site to ...
based inDos Hermanas (Sevilla), SPAIN
Vaxdyn was founded in 2011 as a spin-off established by researchers of the Institute of Biomedicine of Seville, a center of the Andalusian Public Health System and the University of Seville linked to the University Hospital Virgen del Rocío of ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
Work on earlier programmes investigating infections in areas such as respiratory, dermal, ocular and biofilms carries on as research projects, including academic and/or commercial collaborations and grant funded ...
